Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: Prospective cohort study

BMJ (Online)

Volumn 343, Issue 7820, 2011, Pages

  Hippisley Cox, Julia ^a   Coupland, Carol ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ALGORITHM; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENTERITIS; FEMALE; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OPEN STUDY; OUTCOME ASSESSMENT; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; RISK PREDICTION ALGORITHM; SEX RATIO; SMOKING HABIT; VALIDATION PROCESS; VARICOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; COHORT STUDIES; ENGLAND; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WALES;

EID: 84859005063     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d4656     Document Type: Article

References (50)

1. Committee, HoCH. The prevention of thromboembolism in hospitalised patients. 1st ed. House of Commons, 2005: 112.
2. Kyrle P.A., Eichinger S. Deep vein thrombosis. Lancet 2005;365:1163-1174 (Pubitemid 40417567)
3. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta M., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
4. Mohr D.N., Silverstein M.D., Heit J.A., Petterson T.M., O'Fallon W.M., Melton L.J. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: A population-based study. Mayo Clin Proc 2000;75:1249-1256
5. Heit J.A., O'Fallon W.M., Petterson T.M., Lohse C.M., Silverstein M.D., Mohr D.N., et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study. Arch Intern Med 2002;162:1245-1248 (Pubitemid 34595030)
6. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L.J. 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000;160:809-815 (Pubitemid 30165241)
7. Hippisley-Cox J., Coupland C. Unintended effects of statins in men and women in England and Wales: Population based cohort study using the QResearch database. BMJ 2010;340:c2197.
8. Parker C., Coupland C., Hippisley-Cox J. Antipsychotic drugs and risk of thromboembolism: Nested case-control study. BMJ 2010;341:c4245.
9. Geerts W.H., Heit J.A., Clagett G.P., Pineo G.F., Colwell C.W., Anderson F.A. Jr, et al. Prevention of venous thromboembolism. Chest 2001;119(suppl 1):132-75S.
10. National Institute for Clinical Excellence. Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Nice guideline 92. National Institute for Clinical Excellence, 2010:50.
11. Lawrenson R., Todd J.C., Leydon G.M., Williams T.J., Farmer R.D. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000;49:591-596 (Pubitemid 30326559)
12. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Minhas R., Sheikh A., et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ 2008;336:1475.
13. Hippisley-Cox J., Coupland C., Robson J., Sheikh A., Brindle P. Predicting risk of type 2 diabetes in England and Wales: Prospective derivation and validation of QDScore. BMJ 2009;338:b880.
14. Galanter W.L., Thambi M., Rosencranz H., Shah B., Falck S., Lin F-J, et al. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm 2010;67:1265-1273
15. Heit J.A. The epidemiology of venous thromboembolism in the community: Implications for prevention and management. J Thrombosis Thrombolysis 2006;21:23-29 (Pubitemid 43231124)
16. Lidegaard O., Lokkegaard E., Svendsen A.L., Agger C. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ 2009;339:b2890.
17. Jick S.S., Kaye J.A., Russmann S., Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception 2006;73:566-570
18. Van Hylckama Vlieg A., Helmerhorst F.M., Vandenbroucke J.P., Doggen C.J.M., Rosendaal F.R. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study. BMJ 2009;339:b2921.
19. Smith N.L., Heckbert S.R., Lemaitre R.N., Reiner A.P., Lumley T., Weiss N.S., et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004;292:1581-1587 (Pubitemid 39314964)
20. Canonico M., Plu-Bureau G., Lowe G.D.O., Scarabin P-Y Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis. BMJ 2008;336:1227.
21. Roberts H. Type of hormone replacement therapy and risk of venous thromboembolism. BMJ 2008:336:1203.
22. Lutsey P.L., Virnig B.A., Durham S.B., Steffen L.M., Hirsch A.T., Jacobs D.R. Jr, et al. Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 2010;100:1506-1513
23. Samama M.M., Dahl O.E., Quinlan D.J., Mismetti P., Rosencher N. Quantification of risk factors for venous thromboembolism: A preliminary study for the development of a risk assessment tool. Haematologica 2003;88:1410-1421 (Pubitemid 38029726)
24. Alikhan R., Cohen A.T., Combe S., Samama M.M., Desjardins L., Eldor A., et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: Analysis of the MEDENOX Study. Arch Intern Med 2004;164:963-968 (Pubitemid 38581515)
25. Ng T.M.H., Tsai F., Khatri N., Barakat M.N., Elkayam U. Venous thromboembolism in hospitalized patients with heart failure: Incidence, prognosis, and prevention. Circ Heart Fail 2010;3:165-173
26. Matthew J.G., Joe W., Timothy R.C. Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. Lancet 2010;375:657-663
27. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542-548 (Pubitemid 38372979)
28. Lee A.Y.Y., Levine M.N. Venous thromboembolism and cancer: Risks and outcomes. Circulation 2003;107:17-21.
29. Couturaud F., Leroyer C., Julian J.A., Kahn S.R., Ginsberg J.S., Wells P.S., et al. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest 2009;136:1537-1545
30. Hippisley-Cox J., Coupland C. Predicting the risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of the QFractureScore. BMJ 2009;339:b4229.
31. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. BMJ 2007;335:136.
32. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: A validation study. Heart 2008;94:34-39
33. Collins G.S., Altman D.G. An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study. BMJ 2009;339:b2584.
34. Schafer J., Graham J. Missing data: Our view of the state of the art. Psychological Methods 2002;7:147-177
35. Group T.A.M. Academic medicine: Problems and solutions. BMJ 1989;298:573-579
36. Steyerberg E.W., Van Veen M. Imputation is beneficial for handling missing data in predictive models. J Epidemiol Community Health 2007;60:979. (Pubitemid 47208539)
37. Moons K.G.M., Donders R.A.R.T., Stijnen T., Harrell F.J. Using the outcome for imputation of missing predictor values was preferred. J Epidemiol Community Health 2006;59:1092.
38. Rubin D.B. Multiple imputation for non-response in surveys. John Wiley, 1987.
39. Royston P., Ambler G., Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-974 (Pubitemid 29525041)
40. Hosmer D., Lemeshow S. Applied logistic regressiom . John Wiley & Sons Inc, 1989.
41. Royston P. Explained variation for survival models. Stata J 2006;6:1-14.
42. Royston P., Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004;23:723-748 (Pubitemid 38279510)
43. Heinemann L., DoMinh T., Assmann A., Schramm W., Schurmann R., Hilpert J., et al. VTE risk assessment - a prognostic model: BATER Cohort Study of young women. Thrombosis J 2005;3:5.
44. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-4907
45. Jick H., Jick S.S., Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768
46. Majeed A. Sources, uses, strengths and limitations of data collected in primary care in England. Health Stat 2004:5-14.
47. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L.J. 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998;158:585-593 (Pubitemid 28144815)
48. Heinemann L.A., Dinger J.C. Range of published estimates of venous thromboembolism incidence in young women. Contraception 2007;75:328-336 (Pubitemid 46551070)
49. Koeleman P., Reitsma P., Allaart C., Bertina R. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994;84:1031-1035 (Pubitemid 24245865)
50. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008;359:938-949